CoheSIL to enter silicone breast implant trial:
This article was originally published in Clinica
Executive Summary
McGhan Medical, of Santa Barbara, California, is to begin a multicentre US trial of its new silicone breast implant, CoheSIL. The implant is made of cohesive silicone gel and is encased in a silicone shell that is more durable than previous models. The shell is also designed to hold its shape better than the current saline implants. Around half of the 940 patients in the trial will undergo augmentation and the remainder reconstruction or revision surgery. Safety concerns in the 1980s prompted litigation regarding silicone breast implants, and eventually led to their withdrawal for use in routine breast augmentation in the US.